NARI SiA: Promoting Good Mental Health over Menopause and Beyond presented by Dr Lydia Brown

Value of the Information & Strength of the Argument

The presentation provides valuable information by synthesizing high-quality evidence from prospective studies and the Lancet Series, offering a nuanced perspective on the relationship between menopause and mental health. Dr Brown critically evaluates existing data, such as the 68% prevalence figure, and explains statistical concepts like absolute risk versus odds ratios. She also integrates clinical insights from her work as a psychologist, emphasizing the importance of self-compassion and addressing the broader psychosocial context of midlife. The argumentation is solid, as she supports her claims with specific studies and transparently discusses limitations. She also highlights the need for more research on transgender and gender-diverse individuals, showing a commitment to inclusivity.

Scientific Rigor, Source Quality, Title Accuracy

The presentation demonstrates scientific rigor by relying on peer-reviewed research, including the Lancet Series, and by clearly distinguishing between high-quality prospective studies and lower-quality evidence. Dr Brown is transparent about the limitations of the research and the potential for misinterpretation. The title accurately reflects the content, which focuses on promoting good mental health during and after menopause. The sources are credible, and the speaker provides context for the findings, such as the calculation error in the NAMS guidelines. The presentation is well-structured and evidence-based, with a clear link between the research and clinical implications.

The title accurately reflects the content, which focuses on promoting good mental health during and after menopause.

8/10

Presentation by a senior lecturer and clinical psychologist, based on a Lancet Series paper and other peer-reviewed research. The speaker is transparent about limitations and nuances in the data, and provides context for interpreting statistics. The content is well-structured and grounded in evidence, though it is a seminar presentation rather than a formal peer-reviewed publication.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 02:00Introduction and acknowledgment of traditional owners
• 05:00Overview of the presentation structure and key areas
• 10:00Discussion on the importance of menopause and midlife mental health, including statistics on women aged 45-55
• 15:00Definition of key terms: premenopause, perimenopause, postmenopause
• 20:00Explanation of core symptoms of menopause and the impact of hot flashes
• 25:00Discussion on attitudes towards menopause and aging, and their influence on health outcomes
• 30:00Introduction to the Lancet Series paper on menopause and mental health
• 35:00Findings on major depressive disorder and depressive symptoms during perimenopause
• 40:00Critique of the 68% prevalence figure and explanation of statistical nuances
• 45:00Shift to self-compassion research and its role in promoting mental health

• Lancet Series on menopause — Dr Brown mentions the 2024 Lancet Series paper on menopause and mental health, for which she was lead author.
• North American Menopause Society (NAMS) guidelines — She references NAMS guidelines for managing perimenopausal depression, noting the 68% prevalence figure.
• Study by Levy on attitudes to aging — She cites a seminal study by Levy showing that positive attitudes to aging are associated with longer lifespan.
• Stanford study on menopause penalty — She mentions a study from Stanford this year about the 'menopause penalty' and its economic impact.

• Lancet Series on menopause — The presentation aligns with the findings and recommendations of the Lancet Series, which Dr Brown co-authored.
• NAMS guidelines — While Dr Brown critiques the 68% figure, the guidelines themselves are a recognized source on menopause management.

• NAMS guidelines (68% prevalence figure) — Dr Brown suggests that the 68% prevalence of depressive symptoms during perimenopause reported in NAMS guidelines may be a calculation error, as her analysis of the underlying data indicates a lower prevalence.